High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome

Pediatric Nephrology

Volumn 22, Issue 3, 2007, Pages 403-408

  Wasilewska, Anna ^a   Zoch Zwierz, Walentyna ^a   Tobolczyk, Jolanta ^a   Tenderenda, Edyta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Children; Cyclosporine; hs CRP; Nephrotic syndrome

Indexed keywords

C REACTIVE PROTEIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISONE;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LONG TERM CARE; MALE; NEPHELOMETRY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RELAPSE;

ADOLESCENT; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME; PREDNISONE; RECURRENCE;

EID: 34248659390     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0336-7     Document Type: Article

References (23)

1. Ordonez JD, Hiatt RA, Killebrew EJ, Fireman BH (1993) The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 44:638-642
2. Watts GF, Herrmann S, Dogra GK, Playford DA, Best JD, Thomas MA, Irish A (2001) Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int 60:182-189
3. Suranyi MG, Guasch A, Hall BM, Myers BD (1993) Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 21:251-259
4. Stenvinkel P, Ottosson-Seeberger A, Alvestrand A (1995) Renal hemodynamics and sodium handling in moderate renal insufficiency: The role of insulin resistance and dyslipidemia. J Am Soc Nephrol 5:1751-1760
5. Zdrojewski T, Chwojnicki K, Bandosz P, Konarski R, Wyrzykowski B (2006) Distribution of C-reactive protein and its relation to arterial hypertension in a country representing a high-risk region for cardiovascular diseases. Blood Press 15:20-26
6. Pfutzner A, Forst T (2006) High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther 8:28-36
7. Du Clos TW, Mold C (2004) C-reactive protein: An activator of innate immunity and a modulator of adaptive immunity. Immunol Res 30:261-277
8. Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, Fricke L, Steinhoff J (2003) The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 33:152-161
9. Blake GJ, Ridker PM (2002) Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252:283-294
10. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N (2001) Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part 2. Clin Chem 47:418-425
11. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N (2000) Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 46:461-468
12. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E (2004) C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 50:1762-1768
13. Shah SJ, Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, Foster E, Chatterjee K, Michaels AD (2006) High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. J Card Fail 2:61-65
14. Stenvinkel P, Lindholm B (2005) C-reactive protein in end-stage renal disease: Are there reasons to measure it? Blood Purif 23:72-78
15. Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin Chem 47:403-411
16. Ridker PM (2004) High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit. Am Heart J 148:S19-S26
17. Ueland T, Vissers MN, Wiegman A, Rodenburg J, Hutten B, Gullestad L, Ose L, Rifai N, Ridker PM, Kastelein JJ, Aukrust P, Semb AG (2006) Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest 36:147-152
18. Eskola J, Holmberg C, Koskimies O (1986) C-reactive protein - an indicator of generalized bacterial infection in children with nephrotic syndrome. Acta Paediatr Scand 75:846-848
19. Araujo F, Pereira AC, Latorre Mdo R, Krieger JE, Mansur AJ (2004) High-sensitivity C-reactive protein concentration in a healthy Brazilian population. Int J Cardiol 97:433-438
20. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, Park JR, Kim SW (2003) High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 16:429-433
21. Coulon J, Willems D, Dorchy H (2005) Increase in C-reactive protein plasma levels during diabetes in infants and young adults. Presse Med 34:89-93
22. Li C, Yang CW, Kim WY, Jung JY, Cha JH, Kim YS, Kim J, Bennett WM, Bang BK (2003) Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine. Am J Physiol Renal Physiol 284:F389-F398
23. Nakahara C, Kanemoto K, Saito N, Oyake Y, Kamoda T, Nagata M, Matsui A (2001) C-reactive protein frequently localizes in the kidney in glomerular diseases. Clin Nephrol 55:365-370